In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve pre...
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Inhibiteurs des Janus kinases/usage thérapeutique,
COVID-19/traitement médicamenteux,
Antiviraux/usage thérapeutique,
Ivermectine/usage thérapeutique,
Hydroxychloroquine/usage thérapeutique,
Plasma sanguin/immunologie,
Fluvoxamine/usage thérapeutique,
Colchicine/usage thérapeutique,
Immunisation passive,
Récepteurs à l'interleukine-6/usage thérapeutique,
Lopinavir/usage thérapeutique,
Hormones corticosurrénaliennes/usage thérapeutique
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/traitement médicamenteux,
Hormones corticosurrénaliennes/usage thérapeutique,
Antiviraux/usage thérapeutique,
COVID-19/complications,
Embolie pulmonaire/complications,
Poumon/anatomopathologie,
Anticoagulants/usage thérapeutique,
Dabigatran/usage thérapeutique,
Héparine/usage thérapeutique,
4-Hydroxycoumarines/usage thérapeutique,
Acide acétylsalicylique/usage thérapeutique
This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
In this ...
Falavigna, Maicon;
Stein, Cinara;
Amaral, José Luiz Gomes do;
Azevedo, Luciano Cesar Pontes de;
Belli, Karlyse Claudino;
Colpani, Verônica;
Cunha, Clóvis Arns da;
Dal-Pizzol, Felipe;
Dias, Maria Beatriz Souza;
Ferreira, Juliana Carvalho;
Freitas, Ana Paula da Rocha;
Gräf, Débora Dalmas;
Guimarães, Hélio Penna;
Lobo, Suzana Margareth Ajeje;
Monteiro, José Tadeu;
Nunes, Michelle Silva;
Oliveira, Maura Salaroli de;
Prado, Clementina Corah Lucas;
Santos, Vania Cristina Canuto;
Silva, Rosemeri Maurici da;
Sobreira, Marcone Lima;
Veiga, Viviane Cordeiro;
Vidal, Ávila Teixeira;
Xavier, Ricardo Machado;
Zavascki, Alexandre Prehn;
Machado, Flávia Ribeiro;
Carvalho, Carlos Roberto Ribeiro de.
Há diversas terapias sendo utilizadas ou propostas para a COVID-19, muitas carecendo de apropriada avaliação de efetividade e segurança. O propósito deste documento é elaborar recomendações para subsidiar decisões sobre o tratamento farmacológico de pacientes hospitalizados com COVID-19 no Bras...
La presente guía de práctica clínica es un esfuerzo realizado por profesionales del Sistema
Integrado de Salud (SNIS) coordinado por el
Instituto Nacional de Salud (INS) ante la amenaza de la COVID-19 considerada una infección potencialmente mortal causada por el virus SARS-Cov2 y que actualmente rep...
El tratamiento oportuno de personas con COVID-19 busca minimizar el número de
complicaciones y muertes por esta enfermedad. Por ello, el Seguro Social de Salud del Perú
(EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) con la finalidad de
establecer recomendaciones ba...
Salinas, Ariel;
Huaringa-Marcelo, Jorge;
Alfaro-Lozano, José;
Becerra-Chauca, Naysha;
Nieto-Gutierre, Wendy;
Garcia-Gomero, David;
De la Jara, Jesús;
Calderón-Gallegos, Julia;
Flores, Cesar;
Taype-Rondan, Alvaro;
Timaná-Ruiz, Raúl;
Salvador-Salvador, Stefany;
Carrera-Acosta, Lourdes;
Gamboa-Cárdenas, Rocío.
La Artritis Reumatoide (AR) tiene adversas consecuencias en la salud su diagnóstico temprano y manejo óptimo requiere recomendaciones basadas en evidencia de alta calidad adaptadas a cada sistema de salud. Objetivo: Proveer recomendaciones clínicas basadas en evidencia para el diagnóstico y manejo in...
Primary immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia in children, with a reported incidence of 1.1-12.5 cases per 100 000 children. However, currently, there are several definitions of ITP, as well as diagnostic and therapeutic approaches. To develop an evidence-based clinic...
This guideline covers diagnosing and managing bronchiolitis in babies and children. It aims to help
healthcare professionals diagnose bronchiolitis and identify if babies and children should be cared
for at home or in hospital. It describes treatments and interventions that can be used to help with
the s...
